PRRT2 and cancer: The ability of PKC-θ to induce transcription was confirmed in mesenchymal transition and breast cancer stem cells, where PKC-θ was able to elicit inducible transcription programs that drive mesenchymal differentiation and cancer stem cell formation (84).